Shattuck Labs, Inc. (STTK) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $3.94M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $3.94M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $3.94M |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 9.53M USD | Liabilities |
| Borrowing debt | (m) | |
| Amounts owed to suppliers | 3.94M USD | Accounts Payable, Current |
| Total deferred revenue | (m) | Contract with Customer, Liability, Current · Contract with Customer, Liability, Noncurrent |
| Deferred revenue due within one year | (m) | Contract with Customer, Liability, Current |
| Deferred revenue due after one year | (m) | Contract with Customer, Liability, Noncurrent · Contract with Customer, Liability, Current |
| Reported other obligations due within one year | (m) | |
| Reported other noncurrent obligations | (m) | |
| Deferred revenue included in other noncurrent obligations | (m) | Contract with Customer, Liability, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $2.67M |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.94M | (m) | (m) | (m) | $9.53M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $1.25M | (m) | (m) | (m) | $6.29M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $2.10M | (m) | (m) | (m) | $8.64M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $1.16M | (m) | (m) | (m) | $7.09M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $475.00K | (m) | (m) | (m) | $7.35M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $1.53M | (m) | (m) | (m) | $9.58M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $2.42M | (m) | (m) | (m) | $11.42M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $2.93M | (m) | (m) | (m) | $15.14M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $2.82M | (m) | (m) | (m) | $18.00M | (m) | $3.00M | (m) | (m) | (m) |
| 2024-03-31 | (m) | $2.15M | (m) | (m) | (m) | $17.52M | (m) | $4.61M | (m) | (m) | (m) |
| 2023-12-31 | (m) | $1.59M | (m) | (m) | (m) | $14.86M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $2.02M | (m) | (m) | (m) | $17.67M | (m) | $557.00K | (m) | (m) | (m) |
| 2023-06-30 | (m) | $2.01M | (m) | (m) | (m) | $16.81M | (m) | $743.00K | (m) | (m) | (m) |
| 2023-03-31 | (m) | $5.13M | (m) | (m) | (m) | $20.02M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $7.17M | (m) | (m) | (m) | $29.17M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $3.04M | (m) | (m) | (m) | $23.52M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $5.67M | (m) | (m) | (m) | $28.81M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $2.59M | (m) | (m) | (m) | $21.55M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $10.01M | $0.00 | (m) | (m) | $26.80M | (m) | $0.00 | $0.00 | (m) | $0.00 |
| 2021-09-30 | (m) | $3.25M | $30.08M | (m) | (m) | $49.40M | (m) | $2.80M | $27.28M | (m) | $0.00 |
| 2021-06-30 | (m) | $1.01M | $31.99M | (m) | (m) | $46.69M | (m) | $2.78M | $29.21M | (m) | $0.00 |
| 2021-03-31 | (m) | $3.00M | $27.75M | (m) | (m) | $38.19M | (m) | $9.66M | $18.09M | (m) | $0.00 |
| 2020-12-31 | (m) | $1.75M | $29.03M | (m) | (m) | $39.13M | (m) | $7.73M | $21.31M | (m) | $0.00 |
| 2020-09-30 | (m) | $1.35M | $28.34M | (m) | (m) | $37.11M | (m) | $8.61M | $19.72M | (m) | $0.00 |
| 2019-12-31 | (m) | $3.05M | $22.46M | (m) | (m) | $30.45M | (m) | $12.89M | $9.57M | (m) | $0.00 |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |